Latest news for PharmAust (OTC:PAAFF) Stock

PharmAust Ltd operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer. It also provides medicinal and synthetic chemistry services on a contract basis to the drug discovery and pharmaceutical industries.

PharmAust Ltd

PharmaCielo Ltd. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/PCLO#TSXV">PCLO</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PCLOF#OTC">PCLOF</a>) announced its financial results on Thursday for the fourth quarter and year ended December 31, 2023, as well as for the first quarter ended March 31, 2024.
The Canadian parent of Colombia&#8217;s cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., also said that effective as of July 3, 2024, its principal regulator, the Ontario Securities Commission has revoked its failure to file a cease trade order that was issued on May 7, 2024, due to the delay in filing its audited annual consolidated financial statements for the year ended December 31, 2023.
&#8220;Our team has been unwavering in their efforts to drastically reduce costs and optimize operations while expanding our sales reach," said Marc Lustig, chairman and CEO of PharmaCielo. "The global landscape for cannabinoid-based drugs and therapeutics is expanding, and we are strategically positioned to seize opportunities in regions such as Latin America, Australia, and Europe."
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/04/38184878/this-latin-american-cannabis-co-plans-to-expand-in-thailand-amid-significant-shifts-in-weed-regu">This Latin American Cannabis Co. Plans To Expand In Thailand Amid Significant Shifts In Weed Regulation Landscape</a>
<h3 class="wp-block-heading">Q1 2024 Financial Highlights</h3>
<ul>
<li>Revenue totaled CA$240 000 ($176,200), compared to CA$786 000 in the prior year's period and CA$244 000 in the prior quarter.</li>
<li>Adjusted EBITDA came in negative at $1.26 million, representing a year-over-year improvement from an adjusted EBITDA loss of CA$1.9 million in the first quarter of fiscal 2023 and an adjusted EBITDA loss of CA$1.4 million in the fourth quarter.</li>
<li>Net loss was CA$2.4 million, down from a net loss of CA$3.5 million in the quarter ended March 31, 2023, and CA$6.4 million net loss in the prior period.</li>
<li>The company reduced salaries and wages by $406,445, office and general expenses by $157,498 and consulting fees by $61,723, all compared to the quarter ended March 31, 2023.</li>
</ul>
<h3 class="wp-block-heading">FY 2023 Financial Highlights</h3>
<ul>
<li>Revenue amounted to CA$1.54 million, down from CA$5.3 million in the prior year.</li>
<li>Adjusted EBITDA came in negative at CA$6.76 million, down from CA$7.2 million for the twelve months ended Dec. 31, 2022.</li>
<li>Net loss totaled CA$16.3 million, up from a CA$14.5 million net loss in the prior year.</li>
<li>The company reduced consulting fees by CA$235,761 in 2023, office and general expenses by $419,543, and professional fees by $235,962, all compared to the year ended December 31, 2022.</li>
</ul>
PharmaCielo reported the TSX Venture Exchange has changed its tier classification from tier 1 to tier 2, effective June 20, 2024, as the company does not meet the exchange&#8217;s tier 1 continued listing requirements.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/23/11/36001416/cannabis-extracts-producer-pharmacielo-narrows-loss-cuts-expenses-in-q3-ceo-projects-higher-prof">Cannabis Extracts Producer PharmaCielo Narrows Loss, Cuts Expenses In Q3, CEO Projects Higher Profitability</a></li>
</ul>
To learn more about cannabis stocks, come, join us at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">Get your tickets now</a> before prices surge by following <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">this link</a>.

Cannabis

Earnings

News

PCLOF

TSXV:PCLO

PharmaCielo Cannabis Co. Narrows Net Loss By 31% YoY In Q1, CEO Says Cost Reduction Efforts Showing Results

Geely Automobile Holdings Ltd (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GELYY#OTC">GELYY</a>) is reportedly set to unveil its first premium electric vehicle (EV) to South Korea by 2026, marking an effort by Chinese carmakers to penetrate a market still dominated by Hyundai Motor Co. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HYMTF#OTC">HYMTF</a>) and Kia Corp.
Geely&#8217;s luxury EV brand, Zeekr Intelligent Technology Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZK#NYSE">ZK</a>), which<a target="_blank" href="https://www.benzinga.com/markets/equities/24/05/38756035/chinas-zeekr-prices-us-ipo-at-top-end-of-estimated-range-whats-on-the-cards" rel="noreferrer noopener"> recently went public in the U.S.,</a> plans to open showrooms in Seoul and Gyeonggi province by the end of next year, with deliveries starting in early 2026, reported <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-07-05/geely-plans-to-introduce-zeekr-ev-brand-in-korea-by-early-2026?srnd=industries-v2&amp;sref=TBDibEcD" rel="noreferrer noopener">Bloomberg</a>.
The first model expected to hit the South Korean market is the Zeekr 001, an EV with a range of up to 620 kilometers (385 miles) per charge. However, these plans are not yet finalized, the report added.
Chinese automakers face challenges due to South Korea&#8217;s new rule favoring EVs with higher recycled metal content, disadvantaging those using LFP batteries, common in Chinese vehicles.
Nevertheless, Geely and other Chinese brands like BYD Company (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) are eyeing South Korea amid <a target="_blank" href="https://www.benzinga.com/news/24/06/39306681/fresh-eu-tariffs-could-slow-down-tesla-chinese-rivals-but-warren-buffett-backed-byd-can-profitably-e" rel="noreferrer noopener">high tariffs in Europe and the U.S.</a>
Related Read:<a target="_blank" href="https://www.benzinga.com/news/24/07/39592293/tesla-rival-byds-ev-sales-jump-21-in-q2-details" rel="noreferrer noopener"> </a><a target="_blank" href="https://www.benzinga.com/news/24/07/39592293/tesla-rival-byds-ev-sales-jump-21-in-q2-details" rel="noreferrer noopener">Tesla Rival BYD&#8217;s EV Sales Jump 21% In Q2: Details</a>
In 2022, Geely acquired a 34% stake in Renault&#8216;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RNSDF#OTC">RNSDF</a>) Korean unit, deepening their collaboration on eco-friendly models.
Additionally, the Polestar 4, an electric SUV from Geely-controlled Volvo AB (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VOLVF#OTC">VOLVF</a>), will be produced at Renault Korea&#8217;s Busan plant starting in late 2025.
Geely has partnered with Korea&#8217;s SK Group for battery development and Posco International Inc. for the sales and servicing of its commercial vehicles in the country.
This reflects a strategic effort to establish a strong foothold in the South Korean EV market.
The report quoted Lee Hang-Koo, head of the Jeonbuk Institute of Automobile Convergence Technology, who noted significant demand for premium EVs in South Korea.
Price Action: GELYY shares closed higher by 2.67% at $22.66 on Wednesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/06/39253633/volvo-car-shifts-ev-production-to-belgium-from-china-as-eu-tariff-threat-looms-report" target="_blank" rel="noreferrer noopener">Volvo Car Shifts EV Production To Belgium From China As EU Tariff Threat Looms: Report</a></li>
</ul>

Equities

Media

General

BYDDY

GELYY

HYMTF

RNSDF

TSLA

VOLVF

China's Geely Targets South Korea For Premium EV Debut By 2026: Report

B of A Securities analyst Jason Zemansky maintains Insmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) with a Buy and maintains $83 price target.

Price Target

Analyst Ratings

INSM

B of A Securities Maintains Buy on Insmed, Maintains $83 Price Target

Jefferies analyst Kaumil Gajrawala maintains Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) with a Buy and raises the price target from $310 to $311.

Jefferies Maintains Buy on Constellation Brands, Raises Price Target to $311

New Charter Rate $28,700/Day Minus 5% Commission, Effective July 18, 2024, Until October 1, 2025 To December 15, 2025

Contracts

Diana Shipping Extends Time Charter Contract With Nippon Yusen For m/v Los Angeles

Homes are selling below their asking prices for the first time in late spring since the onset of the COVID-19 pandemic, signaling a potential return to a buyer&#8217;s market. 
According to a report issued by Redfin, during the four weeks ending June 23, the typical U.S. home sold for 0.3% less than its list price, marking a pivot from the same period in previous years when homes consistently sold at or above asking prices. Just one year ago, homes were selling for exactly their list price, while two years ago, they sold 2% above the list price.
Don't Miss:
<ul>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a></li>
<li>Miami is expected to take New York's place as the U.S. Financial Capital.<a href="https://www.benzinga.com/money/miami-take-new-yorks-place-financial-capital"> Here's how you can invest in the city before that happens</a>.</li>
</ul>
A change in supply and demand underpins the move. New listings have surged 8.2% year over year nationwide, the report said, while pending home sales have dropped 4.3% — the largest decline in four months. The increased inventory gives buyers more options and, consequently, more negotiating power. 
Further evidence is seen in the declining share of homes selling above the asking price. Only 32.3% of homes sold were over the listed price during the period Redfin analyzed, the lowest share for any late spring since 2020, down from 36% a year earlier. 
Sellers are also adjusting their strategies in response to the changing market. On average, nearly 7% of home sellers reduced their asking prices — the highest level since November 2022 and up from 4.7% a year ago. 
Despite the shifts, affordability remains a hurdle for many potential buyers. The median home sale price has reached an all-time high of $397,250, up 4.9% year over year. Mortgage rates, while down from May&#8217;s six-month high, are still hovering near 7%, resulting in a typical homebuyer&#8217;s monthly payment just $50 below all-time highs at $2,785. 
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Will the surge continue or decline on real estate prices?<a href="https://www.benzinga.com/money/realbricks"> People are finding out about risk-free real estate investing with just $100</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
According to the Mortgage Bankers Association, mortgage purchase applications increased 1% week-over-week as of June 21, though they remain down 13% year-over-year. The Redfin Homebuyer Demand Index, which measures requests for tours and other homebuying services, was up 5% from a month earlier but down 14% year-over-year. "Some buyers think they can get a deal because they're hearing the market is cool, and some sellers think every home will sell for top dollar no matter the condition," Marije Kruythoff, a Redfin agent, was quoted in the report. "In reality, everything depends on the house and the location." &nbsp;
In cities where inventory has increased more rapidly, buyers find greater negotiating opportunities. For example, the median sales price of homes in pandemic-era boom towns like San Antonio and Austin, Texas, declined 2.5% in the period tracked by Redfin. 
As the summer progresses, experts anticipate that home prices will moderate further. However, they caution that much depends on broader economic factors, including inflation trends and Federal Reserve policies that could impact mortgage rates. 
Read Next:
<ul>
<li>Elon Musk&#8217;s secret mansion in Austin revealed through court filings.<a href="https://www.benzinga.com/money/elon-musk-secret-mansion-austin-nada"> Here&#8217;s how to invest in the city&#8217;s growth before prices go back up.</a></li>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
</ul>

Real Estate

Buyer's Market Is Emerging As Homes Sell Below List Price For First Time Since Pandemic

The Hungarian Prime Minister, Viktor Orbán, is scheduled to meet with Russian President Vladimir Putin this Friday, following his recent visit to Kyiv.
What Happened: Orbán&#8217;s meeting with Putin, confirmed by one Hungarian and two EU officials, is seen as an attempt to mediate between Russia and Ukraine, Financial Times <a href="https://www.ft.com/content/d3b86bec-f847-4ed8-945e-8f00c0fe0066">reported</a> on Friday. This follows Orbán&#8217;s surprise visit to Ukraine on Monday, where he spent three hours with Ukrainian President Volodymyr Zelenskyy.
Despite Orbán&#8217;s efforts, Charles Michel, the outgoing president of the European Council, stated that the EU rotating presidency has no mandate to engage with Russia on behalf of the EU. He emphasized that &#8220;Russia is the aggressor, Ukraine is the victim. No discussions about Ukraine can take place without Ukraine.&#8221;
Orbán&#8217;s upcoming trip was first reported by Szabolcs Panyi, an investigative journalist with the east European VSquare group. The Hungarian Prime Minister has suggested a ceasefire deadline to Zelenskyy to pave the way for full peace talks with Russia.
Why It Matters: Orbán&#8217;s visit to Moscow will be the first by an EU leader since the unsuccessful peace-brokering attempt by Austrian Chancellor Karl Nehammer in April 2022. Orbán has previously met with Putin twice since the full-scale invasion of Ukraine by Russia. Earlier, Putin and Chinese President Xi Jinping had expressed ambitions for a<a href="https://www.benzinga.com/news/24/07/39633180/xi-putin-pitch-eurasian-security-club-in-the-face-of-real-risks-as-counterweight-to-west-must-safegu"> new Eurasian security</a> system.
See Also: <a href="https://www.benzinga.com/news/24/07/39611807/biden-trump-deadlock-ends-after-debate-new-poll-indicates-defection-of-voter-category-that-should-wo?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Biden-Trump Deadlock Ends After Debate: New Poll Indicates Defection Of Voter Category That Should Worry</a> 
<a href="https://www.benzinga.com/news/24/03/37604471/man-of-peace-trump-wont-fund-ukraine-if-elected-president-says-viktor-orb-n-he-will-not-give-a-penny">Back in March</a>, Orbán had stated that former U.S. President Donald Trump plans to stop all financial aid to Ukraine if he is victorious in the next U.S. presidential election. This announcement has significant implications for the ongoing conflict in the region.
Meanwhile, Zelenskyy has <a href="https://www.benzinga.com/news/24/07/39617560/zelenskyy-presses-trump-to-tell-how-to-finish-ukraine-russia-war">been pressing Trump</a> to reveal his plan for a swift end to the ongoing Russia-Ukraine war. &#8220;If Trump knows how to finish this war, he should tell us today," Zelenskyy asserted.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39611479/odds-of-kamala-harris-replacing-joe-biden-as-democratic-presidential-candidate-raised-by-c?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Odds Of Kamala Harris Replacing Joe Biden As Democratic Presidential Candidate Raised By Crypto Bettors, Memecoin Themed On Her Surges 126%</a></li>
</ul>
Photo via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Politics

Global

Hungary Prime Minister Viktor Orbán To Meet Russian President After Surprise Ukraine Visit In Attempt To Broker Peace

The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Allied Gaming &amp; Entertainment</h3>
<ul>
<li>The Trade: Allied Gaming &amp; Entertainment Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGAE#NASDAQ">AGAE</a>) 10% owner Knighted Pastures LLC <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 360,000 shares</a> at an average price of $1.27. To acquire these shares, it cost around $456,750.</li>
<li>What's Happening: Allied Gaming &amp; Entertainment, on June 15, entered into a termination agreement with Elite Fun Entertainment Limited and its affiliates.</li>
<li>What Allied Gaming &amp; Entertainment Does: Allied Gaming &amp; Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.</li>
</ul>
<h3 class="wp-block-heading">Archer Aviation</h3>
<ul>
<li>The Trade: Archer Aviation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) 10% owner SFS UK 1 LTD. <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 17,401,153 shares at</a> an average price of $3.16. To acquire these shares, it cost around $55 million.</li>
<li>What's Happening: On July 2, Archer Aviation announced it received an additional $55 million investment from Stellantis following its recent flight test milestone.</li>
<li>What Archer Aviation Does: Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks.</li>
</ul>
<h3 class="wp-block-heading">Tempest Therapeutics</h3>
<ul>
<li>The Trade: Tempest Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) Chief Medical Officer Samuel Whiting <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 4,672 shares</a> at an average price of $2.13. The insider spent around $9,951 to buy those shares. </li>
<li>What's Happening: On June 20, The company announced data from the ongoing global randomized Phase 1b/2 clinical study for amezalpat2.</li>
<li>What Tempest Therapeutics Does: Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/24/07/39617741/top-3-health-care-stocks-that-may-crash-this-quarter">Top 3 Health Care Stocks That May Crash This Quarter</a>

Long Ideas

Penny Stocks

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

ACHR

AGAE

Tempest Therapeutics, Inc. - Common Stock

TPST

$55M Bet On Archer Aviation? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

JP Morgan analyst Andrea Teixeira maintains Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) with a Overweight and raises the price target from $291 to $320.

JP Morgan Maintains Overweight on Constellation Brands, Raises Price Target to $320

Crypto
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39639419/amid-bitcoin-crash-peter-schiff-forecasts-prolonged-bear-market-dont-say-i-didnt-warn-you-">Amid Bitcoin Crash, Peter Schiff Forecasts Prolonged Bear Market: &#8216;Don&#8217;t Say I Didn&#8217;t Warn You HODLers&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39638873/bitcoin-bull-mike-novogratz-brings-up-reagan-amid-question-mark-hanging-over-bidens-candid">Bitcoin Bull Mike Novogratz Brings Up Reagan Amid Question Mark Hanging Over Biden&#8217;s Candidacy: &#8216;Power Is A Strange Drug&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39638571/bitcoin-ethereum-dogecoin-in-full-meltdown-as-mt-gox-moves-2-7b-to-new-wallet-king-crypto-">Bitcoin, Ethereum, Dogecoin In Full Meltdown As Mt.Gox Moves $2.7B To New Wallet: King Crypto Decline To $51K Feared By Analyst</a></li>
</ul>
US Markets
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39644939/wall-street-on-wait-and-watch-mode-ahead-of-jobs-data-bitcoin-plummets-tesla-extends-climb-analyst-">Wall Street On &#8216;Wait-And-Watch&#8217; Mode Ahead Of Jobs Data, Bitcoin Plummets, Tesla Extends Climb: Analyst Flags 2 Factors That Pose Risk To Rally</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39639846/s-p-500-settles-at-new-record-even-as-fear-greed-index-moves-to-fear-zone">S&amp;P 500 Settles At New Record Even As Fear &amp; Greed Index Moves To &#8216;Fear&#8217; Zone</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39636949/british-pound-european-stocks-surge-ahead-of-uk-election-results-bitcoin-plummets-w">British Pound, European Stocks Surge Ahead Of UK Election Results; Bitcoin Plummets: What&#8217;s Driving Markets Thursday?</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39636120/why-the-s-p-500-is-set-for-a-strong-second-half-dont-give-up-on-the-bull-market-yet">Why The S&amp;P 500 Is Set For A Strong Second Half: &#8216;Don&#8217;t Give Up On The Bull Market Yet,&#8217; Says Analyst</a></li>
</ul>
US Politics
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39641760/biden-vs-trump-incumbent-trails-by-widest-margin-in-this-election-cycle-but-more-than-half-unenthusi">Biden Vs. Trump: Incumbent Trails By Widest Margin In This Election Cycle But More Than Half Unenthusiastic About Either, 2 Separate Polls Find</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39640413/im-not-going-anywhere-biden-rebuffs-calls-for-withdrawal-from-presidential-election-during-fourth-of">&#8216;I&#8217;m Not Going Anywhere:&#8217; Biden Rebuffs Calls For Withdrawal From Presidential Election During Fourth Of July Celebrations</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39638541/trumps-unfounded-claims-kamala-harris-stir-controversy-shes-so-bad-shes-so-pathetic">Trump&#8217;s Unfounded Claims About Kamala Harris Stir Controversy: &#8216;She&#8217;s So Bad, She&#8217;s So Pathetic</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39638455/obama-era-official-says-democrats-discussing-how-to-replace-biden-full-scale-panic-behind-the-scenes">Obama-Era Official Says Democrats Discussing &#8216;How&#8217; To Replace Biden: &#8216;Full-Scale Panic&#8217; Behind The Scenes</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39638417/kamala-harris-warns-of-trumps-threat-to-democracy-amid-speculations-of-her-presidential-candidacy-he">Kamala Harris Warns Of Trump&#8217;s Threat To Democracy, Amid Speculations Of Her Presidential Candidacy: &#8216;He Vowed To Be A Dictator On Day One&#8217;</a></li>
</ul>
World Politics
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39640147/keir-starmer-to-become-uk-prime-minister-as-labour-wins-big-over-rishi-sunaks-conservatives-mohamed">Keir Starmer To Become UK Prime Minister As Labour Wins Big Over Rishi Sunak&#8217;s Conservatives — Mohamed El-Erian Shares Two Key Takeaways</a></li>
</ul>
US Economy
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/24/07/39644869/new-york-federal-reserve-president-highlights-significant-progress-in-taming-infl">New York Federal Reserve President Highlights &#8216;Significant Progress&#8217; In Taming Inflation, But 2% Target &#8216;Still A Way To Go&#8217;</a></li>
</ul>
Tech
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39644569/key-nvidia-supplier-sk-hynix-to-get-further-boost-from-ai-demand-even-after-90-stock-surge-goldman-s">Key Nvidia Supplier SK Hynix To Get Further Boost From AI Demand Even After 90% Stock Surge, Goldman Sachs And Citi Predict</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39641032/why-sharps-technology-shares-are-trading-higher-by-around-32-here-are-20-stocks-moving-premarket">Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39637474/ai-has-the-hallmarks-of-an-inflating-bubble-warns-veteran-wall-street-investor">AI Has &#8216;The Hallmarks Of An Inflating Bubble,&#8217; Warns Veteran Wall Street Investor</a></li>
</ul>
Electric Vehicle
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39645086/leadership-change-at-nio-cfo-resigns-senior-vp-takes-charge">Leadership Change at NIO: CFO Resigns, Senior VP Takes Charge</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39641169/did-nancy-pelosi-miss-a-trick-by-selling-tesla-ahead-of-breakout-ev-makers-stock-up-35-since-con">Did Nancy Pelosi Miss A Trick By Selling Tesla Ahead Of Breakout? EV Maker&#8217;s Stock Up 35% Since Congresswoman&#8217;s Trade</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39640751/tesla-model-y-features-on-chinese-governments-purchase-list-in-a-first-for-elon-musks-company">Tesla Model Y Features On Chinese Government&#8217;s Purchase List In A First For Elon Musk&#8217;s Company</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39640029/teslas-giga-berlin-expansion-gets-environmental-authority-approval-after-chancellor-scholz-voiced-ai">Tesla&#8217;s Giga Berlin Expansion Gets Environmental Authority Approval After Chancellor Scholz Voiced Aim For Brandenburg To Become European Hub For Elon Musk&#8217;s Company</a></li>
</ul>
Consumer
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39640788/toyota-says-it-has-not-found-any-further-wrongdoing-in-certification-applications-beyond-those-repor">Toyota Says It Has Not Found Any Further Wrongdoing In Certification Applications Beyond Those Reported Earlier</a></li>
</ul>
Communication
<ul>
<li><a href="https://www.benzinga.com/government/24/07/39645373/whats-going-on-trump-media-technology-group-stock-on-friday">What&#8217;s Going On With Trump Media &amp; Technology Group Stock On Friday?</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39644878/netflix-disney-challenge-canadian-content-fee-in-court-report">Netflix, Disney Challenge Canadian Content Fee In Court: Report</a></li>
</ul>
Healthcare
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/07/39645630/roches-new-immunotherapy-fails-to-show-benefit-over-mercks-blockbuster-keytruda-in-lung-cancer-pa">Roche&#8217;s New Immunotherapy Fails To Show Benefit Over Merck&#8217;s Blockbuster Keytruda In Lung Cancer Patients</a></li>
</ul>
Financial
<ul>
<li><a href="https://www.benzinga.com/fintech/24/07/39641396/paypals-unfair-contract-term-with-small-businesses-that-led-to-overcharging-ruled-out-by-australian">Paypal&#8217;s &#8216;Unfair Contract Term&#8217; With Small Businesses That Led To Overcharging Ruled Out By Australian Court</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39640049/masayoshi-sons-softbank-negotiates-10b-energy-project-funding-with-banks-report">Masayoshi Son&#8217;s SoftBank Negotiates $10B Energy Project Funding With Banks: Report</a></li>
</ul>
General
<ul>
<li><a href="https://www.benzinga.com/general/psychology/24/07/39636267/tragic-shooting-in-grand-crossing-chicago-two-women-killed-three-boys-critically-injured">Tragic Shooting In Grand Crossing, Chicago: Two Women Killed, Three Boys Critically Injured</a></li>
</ul>
Energy
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39641478/wildfire-risk-forces-suncor-to-shut-down-firebag-oil-sands-site-report">Wildfire Risk Forces Suncor To Shut Down Firebag Oil Sands Site: Report</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39641372/shell-absorbs-charges-pauses-project-q2-outlook-dims-with-impairments-and-biofuels-halt">Shell Absorbs Charges, Pauses Project: Q2 Outlook Dims With Impairments and Biofuels Halt</a></li>
</ul>
Photo courtesy: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

Bitcoin, Ethereum, And Dogecoin Plunge As Mt.Gox Moves $2.7B;  Biden Trails Trump By Widest Margin, But Over Half Unenthusiastic About Either Candidate, Polls Find - Top Headlines Today While US Slept

Tesla Inc.&#8217;s fans and investors are currently celebrating Cybertruck delivery numbers for the second quarter, which they believe outdid other electric trucks in America, including Ford&#8217;s F-150 Lightning. However, there is no public data to back this claim.
What Happened: Tesla&#8217;s Cybertruck handle on X also shared the news, seemingly confirming the prediction while not providing data to back it. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f91d;&#x1f1fa;&#x1f1f8; <a href="https://t.co/u3FIKg24lE">https://t.co/u3FIKg24lE</a>
&mdash; Cybertruck (@cybertruck) <a href="https://twitter.com/cybertruck/status/1808856580944798107?ref_src=twsrc%5Etfw">July 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why Cybertruck Couldn&#8217;t Have Sold More Than Lightning: Tesla&#8217;s Cybertruck is up against Ford&#8217;s F-150 Lightning, Rivian&#8217;s R1T, and GM&#8217;s Silverado EV and Hummer EV pickup in the EV truck segment. While Ford reported earlier this week that it <a href="https://www.benzinga.com/news/24/07/39630731/mustang-mach-e-drives-fords-q2-ev-sales-ahead-of-gm-but-its-still-just-a-fraction-of-elon-musks-tesl">sold 7,902 units of its Lightning</a> in the second quarter in the U.S., <a href="https://www.benzinga.com/news/24/07/39612749/60-000-cadillac-lyriq-drives-gms-q2-ev-sales-after-bolt-is-discontinued">GM said</a> that it delivered 2,196 units of its Silverado EV and 2,929 units of its Hummer EV SUV and pickup trucks combined.
However, neither Tesla nor Rivian gave model-wise sales numbers.
Tesla on Tuesday reported that it delivered 21,551 units of its<a href="https://www.benzinga.com/markets/equities/24/07/39595720/tesla-deliveries-fall-for-second-straight-quarter-but-stock-takes-off-as-q2-numbers-exceed-expec"> more premium models </a>globally in the second quarter. Tesla&#8217;s premium lineup includes not just the Cybertruck but also its Model S sedan and its Model X SUV, making it unclear as to how many Cybertrucks were sold in particular. However, while the Model S and X are sold in markets outside the U.S., the Cybertruck is sold only within the country.
As for Rivian, the company said that it <a href="https://www.benzinga.com/markets/equities/24/07/39595729/why-rivian-automotive-shares-are-gaining-tuesday">delivered 13,790 vehicles in the quarter</a>, including not just its R1T electric trucks but also R1S SUVs.
Tesla started delivering the Cybertruck to customers only in the fourth quarter of 2023. In the second quarter of 2023, Tesla delivered 19,225 Model S and X vehicles, implying that if indeed Cybertruck were to trump the Lightning&#8217;s sales numbers for the second quarter of 2024, its Model S and Model X deliveries should have fallen by at least 29% year-on-year.
Furthermore, according to data from automotive research company Kelley Blue Book, Tesla sold <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38284745/teslas-cybertruck-outpaces-porsche-taycan-in-q1-despite-lagging-behind-fords-f-150-">just 2,803 Cybertrucks in the first quarter</a>, implying that Tesla must have increased its production capacity by at least 182% if it were to have sold more Cybertruck units.
Thus far, it&#8217;s likely that either Ford or Rivian sold more EV pickup trucks than Tesla in the quarter. Tesla, however, did not immediately respond to <a href="https://pro.benzinga.com/dashboard">Benzinga&#8217;s</a> request for comment.
Why Cybertruck Could Have Sold More Than Lightning: Tesla <a href="https://www.benzinga.com/news/24/06/39473764/tesla-recalls-more-than-11-000-cybertrucks-over-applique-detachment-risk-and-nearly-12-000-for-winds">recalled 11,688 Cybertrucks</a> over concerns that its front windshield wiper may stop working owing to a failure of the wiper motors in late June, implying that the company has at least so many of the trucks in the market.
If one were to assume that Tesla only sold 900 Cybertrucks in November and December last year, and 2,803 Cybertrucks in the first quarter of 2024, it would leave the number of Cybertrucks delivered in the second quarter at around 8000 units, higher than the Lightning.
Furthermore, for Rivian, the R1S is more profitable than the R1T, leaving us to assume the company sold more SUVs than pickups in the last three months as it gears towards reporting its <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39594501/from-volkswagen-partnership-to-trimming-costs-and-introducing-cheaper-evs-rivian-st">first-ever quarterly gross profit in the fourth quarter of 2024</a>. Based on this assumption, the R1T sales would have been below the Lightning in the quarter.
While this seems probable, one cannot be sure unless Tesla reveals its Cybertruck sales numbers for the period. 
Why It Matters: Tesla is currently scaling the production of the Cybertruck and aims to make 250,000 annually by 2025. For now, the company has touched a weekly production rate of 1,300 Cybertrucks, Tesla CEO Elon Musk said at Tesla's annual shareholder meeting in the first half of June. The EV maker is looking to increase it further this year to touch 2,500 units by year-end,<a href="https://www.benzinga.com/news/24/06/39330272/tesla-ramping-up-cybertruck-production-to-touch-2-500-units-per-week-non-foundation-series-to-start" target="_blank" rel="noreferrer noopener">&nbsp;he added</a>.
The stainless steel truck has been a celebrity favorite over the past few months likely due to the vehicle&#8217;s unconventional design, high price point, and the few units available on the road. The vehicle pricing starts at $79,990 for the all-wheel drive version and $99,990 for the more premium Cyberbeast version. A lower-priced rear-wheel drive version of the truck will be&nbsp;<a href="https://www.benzinga.com/news/24/04/38130429/new-cybertruck-orders-will-only-be-delivered-in-2025-says-tesla-website" target="_blank" rel="noreferrer noopener">available in 2025</a>, as per the company website, starting at $60,990.
Musk has previously said that production, <a href="https://www.benzinga.com/news/24/07/39590408/tesla-to-deliver-foundation-series-cybertrucks-through-late-2024-due-to-continued-high-demand-contra">and not demand</a>, is the biggest hurdle in ramping up Cybertruck deliveries. The company eventually intends to make the truck a common sight on American roads.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39633301/tesla-ceo-elon-musk-laughs-at-waymo-getting-flagged-down-by-police-for-driving-into-opposing-lanes-o" target="_blank" rel="noreferrer noopener">Tesla CEO Elon Musk Laughs At Waymo Getting Flagged Down By Police For Driving Into Opposing Lanes Of Traffic: ‘Comedy Writes Itself&#8217;</a></li>
</ul>
Photo via Shutterstock

Tech

Tesla Hints Cybertruck Was Most Sold EV Truck In US In Q2, But Elon Musk's Company Has Not Released Data To Back It Up

Adams Diversified Equity Fund, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADX#NYSE">ADX</a>) announced today the commencement of the Fund&#39;s previously announced tender offer to acquire in exchange for cash up to 10%, or 12,405,174 shares, of its issued and outstanding Common Stock, at a price equal to 98% of net asset value per share as of the close of ordinary trading on the New York Stock Exchange (&quot;NYSE&quot;) on August 2, 2024, or, if the tender offer is extended, the day the offer expires (the &quot;Tender Offer&quot;).

Buybacks

Adams Diversified Equity Fund Commences The Fund's Previously Announced Tender Offer To Acquire In Exchange For Cash Up To 10%, Or 12,405,174 Shares, Of Its Issued And Outstanding Common Stock

MRDB

On 5 July 2024, MariaDB Filed With The U.S. SEC An Amendment To Its Amended And Restated Solicitation/Recommendation Statement On Schedule 14D-9 Previously Filed On June 24, 2024

Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) is on track to sell $12 billion of artificial intelligence chips in China this year despite the U.S. export controls, the Financial Times <a target="_blank" href="https://www.ft.com/content/b76ef55b-21cd-498b-ac16-5660908bb8d2" rel="noreferrer noopener">reports</a>.
According to analyst forecasts, the company will deliver more than 1 million new H20 chips, designed to circumvent U.S. restrictions on selling AI processors to Chinese customers.
That figure is nearly double what Huawei is expected to sell for its China-made rival product, Ascend 910B, the FT cites SemiAnalysis, chip consultancy estimates.
Each H20 chip costs between $12,000 and $13,000, suggesting Nvidia could generate over $12 billion in sales, surpassing the $10.3 billion revenue from its entire China business in the previous financial year.
Colette Kress, Nvidia&#8217;s finance chief, noted a significant decline in revenue from its data center segment in China following the imposition of new export controls in October.
Before U.S. export controls, China accounted for more than a quarter of Nvidia&#8217;s total revenues. Even if the H20 chip meets analysts&#8217; expectations, China may account for about 10% of sales this year.
Analysts at Morgan Stanley and SemiAnalysis report that the H20 chip is now shipping in volume and is popular among Chinese customers despite its lower performance than Nvidia&#8217;s US-sold chips.
Most Chinese AI companies have built their AI models on Nvidia&#8217;s ecosystem, making a switch to Huawei&#8217;s infrastructure time-consuming and costly.
Despite the restrictions, Nvidia&#8217;s overall revenues from China, including Hong Kong, grew more than 50% year-on-year to $2.5 billion in the most recent quarter.
Recent reports indicated that Nvidia is under scrutiny because of reports of its <a target="_blank" href="https://www.benzinga.com/government/24/07/39616102/despite-restrictions-nvidia-chips-are-still-reaching-china-wsj" rel="noreferrer noopener">advanced AI chips</a> being smuggled into China.
Around 12,500 AI chips are estimated to be smuggled annually, while Nvidia sold over 2.6 million A100 and H100 chips globally last year.
Nvidia stock gained over 203% in the last 12 months. Investors can gain exposure to Nvidia through SPDR S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and iShares Core S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVV#NYSE">IVV</a>).
Price Action: NVDA shares were trading lower by 0.76% at $127.40 premarket at the last check on Friday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Wikimedia Commons

Government

Regulations

Emerging Markets

NVDA

Is Nvidia Defying US Export Controls? What's Going On?

Orléans, France-based Overseed Biotech, which focuses on agronomic research and development of cannabis-derived medicines, raised 6.7 million euros ($7.25 million) in Series A fundraising round with the goal of becoming the first French manufacturer of 100% medical cannabis medicines, <a href="https://www.eu-startups.com/2024/07/french-biotech-overseed-raises-e6-7-million-to-become-local-manufacturer-of-100-medical-cannabis-medicines/" target="_blank" rel="noreferrer noopener">writes</a> EU-Startups.
"On the French market, we are 2 to 3 years ahead in terms of manufacturing expertise, and will be ready to offer high-quality, high-volume production from day 1," stated Hugues Péribère, CEO and founder of Overseed. "This financing is the final sprint to market access. We are counting on the interest of the authorities to facilitate a rapid assessment of our case so that we can get to market as quickly as possible."
In 2023, France <a target="_blank" href="https://www.benzinga.com/markets/cannabis/23/11/35666979/euro-weed-ukraine-on-verge-of-legalizing-medical-marijuana-cannabis-updates-from-france-germany" rel="noreferrer noopener">took a step toward the generalization of medical marijuana</a>. On Oct. 23rd the government proposed an amendment to the Social Security Financing Bill (PLFSS) concerning medical marijuana. This is the first time, medical cannabis law was presented to France's general medical framework. Under the new proposals, medical marijuana products will be granted a "temporary authorization" for five years, with a possibility of indefinite renewals.
The use and health insurance coverage of medical marijuana is set to start in January 2025. Preparing for this important development in the medical marijuana space, Overseed raised the money. This latest round was secured from Anthony Bourbon&#8217;s Blast.Club and the seed capital fund of the Centre-Val de Loire region are managed by UI Investissement, which supports young innovative companies in the region with the support of the European Union. The round follows up on the biotech's 2.5 million euros seed round in 2022.
Bourbon, founder of Blast.Club, said: "Overseed's scientific rigor and meticulous anticipation of the market make it an innovative player with all the cards in hand to become the market leader in the coming years."
Read Also: <a target="_blank" href="https://www.benzinga.com/markets/cannabis/24/04/38248796/we-want-fewer-people-to-consume-cannabis-german-chancellor-scholz-explains-reform-to-chinese-stu" rel="noreferrer noopener">This Bordeaux Suburb's Experimental Cannabis Legalization Project</a>
Since its launch in 2021, Overseed has been a founding member of the French association of medical cannabis players, Santé France Cannabis. The biotech obtained the 1st French R&amp;D authorization for the Cannabis Sativa plant, developed its research program, and partnered with several suppliers.
Furthermore, Overseed entered into a three-way collaboration with RS/CBM (Molecular Biology Center) and the University Hospital of Orléans for preclinical and clinical work. The idea behind these activities is to research the impacts on other conditions and to confirm efficacy.
The company is focusing on a range of three oral products, that should be put on the market in partnership with a French pharmaceutical company with distribution capacity in France and potentially Europe.
<h2 class="wp-block-heading">Second National Hemp Festival</h2>
Meanwhile, on July 6th-7th, the second National Hemp Festival will be held at Cherveux Castle. Guillaume Dumoulin, a farmer and founder of the agriculture cooperative La Sévrienne, is one of the organizers behind the festival. The event welcomes hemp enthusiasts, manufacturers, growers, processors, entrepreneurs and also local authorities, <a href="https://cannabizeu.com/france-second-national-hemp-festival-at-cherveux-castle/" target="_blank" rel="noreferrer noopener">writes</a> CannaBizEu.
The goal behind this festival is to raise public awareness about hemp benefits and its potential industry development. There will be a roundtable led by professionals sharing their expertise on hemp. Discussions will include both the plant's use in the textile industry and sustainable construction, and also its health and wellness benefits. There will be various demonstrations as well.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/06/39320186/22-8m-europeans-used-weed-last-year-german-university-launches-marijuana-cultivation-course-and-" target="_blank" rel="noreferrer noopener">22.8M Europeans Used Weed Last Year, German University Launches Marijuana Cultivation Course And UK&#8217;s &#8216;Cannabis Martyr&#8217;</a></li>
</ul>
To keep on top of what is happening with cannabis in the US and across Europe, join us at the 19th Benzinga Cannabis Capital Conference, which is coming to Chicago this Oct. 8-9.&nbsp;<a target="_blank" href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" rel="noreferrer noopener">Get your tickets now before</a> prices go up by following&nbsp;<a target="_blank" href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" rel="noreferrer noopener">this link</a>.
Photo: Courtesy of Tinnakorn jorruang via Shutterstock

Eurozone

French Biotech Raises $7.25M In Preparation For Medical Marijuana Program

Beneficient (NASDAQ:<a href="https://www.benzinga.com/stock/BENF#NASDAQ">BENF</a>) (&quot;Ben&quot; or the &quot;Company&quot;), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform, AltAccess, announced that it will release its Fourth Quarter and Full Year Fiscal 2024 financial results before market open on Tuesday, July 9, 2024. Beneficient will host a webcast to present the results on Tuesday, July 9, 2024 at 8:30 a.m. Eastern Daylight Time.

BENF

Beneficient Reschedules Q4 And FY24 Earnings Release To Before Market Open On Tuesday, July 9, 2024

SYLA Launches HOTEL ZUSHI-HAYAMA

In the preceding three months, 6 analysts have released ratings for Betterware de Mexico SAPI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWMX#NYSE">BWMX</a>), presenting a wide array of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $22.5, a high estimate of $22.50, and a low estimate of $22.50. Consistency is reflected as the current average remains at the same level as the previous average price target. 
<img src="https://www.benzinga.com/files/images/story/2024/1720184446_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Betterware de Mexico SAPI among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$22.50</td>
<td>$22.50</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$22.50</td>
<td>$22.50</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$22.50</td>
<td>$22.50</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$22.50</td>
<td>$22.50</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$22.50</td>
<td>$22.50</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$22.50</td>
<td>$22.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Betterware de Mexico SAPI. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Betterware de Mexico SAPI compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Betterware de Mexico SAPI's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Betterware de Mexico SAPI's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BWMX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Betterware de Mexico SAPI analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Betterware de Mexico SAPI</h2>
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided into different categories based on the type of products it sells and includes, kitchen and food preservation, home solutions, bathroom, laundry &amp; cleaning, tech and mobility, and bedroom and wellness products. The JAFRA's segment is divided into fragrance, color, skincare, and toiletries products. The company generates a majority of its revenue from the Beauty and personal care (B&amp;PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.
<h3>Financial Milestones: Betterware de Mexico SAPI's Journey</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Betterware de Mexico SAPI displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 10.36%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: Betterware de Mexico SAPI's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 8.16% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Betterware de Mexico SAPI's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 19.7%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Betterware de Mexico SAPI's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.68% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Betterware de Mexico SAPI's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 3.6.
<h2>How Are Analyst Ratings Determined?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BWMX

Beyond The Numbers: 6 Analysts Discuss Betterware de Mexico SAPI Stock

Throughout the last three months, 5 analysts have evaluated Belden (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDC#NYSE">BDC</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $111.6, a high estimate of $123.00, and a low estimate of $100.00. Witnessing a positive shift, the current average has risen by 7.72% from the previous average price target of $103.60.
<img src="https://www.benzinga.com/files/images/story/2024/1720184439_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Belden among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>William Stein</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$123.00</td>
<td>$119.00</td>
</tr>
<tr>
<td>William Stein</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$119.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Chris Dankert</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Reuben Garner</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>William Stein</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$101.00</td>
<td>$98.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Belden. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Belden compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Belden's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Belden's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BDC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Belden analyst ratings.</a>
<h2>Delving into Belden's Background</h2>
Belden Inc provides signal transmission products to distributors, end-users, installers, and original equipment manufacturers. The firm operates in two segments - Enterprise Solutions and Industrial Solutions. The Enterprise Solutions segment is a provider in network infrastructure solutions, as well as cabling and connectivity solutions for commercial audio/video and security applications. The Industrial Solutions segment is a provider of high-performance networking components and machine connectivity products. It operates in Americas, EMEA and APAC, out of which maximum revenue from Americas.
<h3>Financial Insights: Belden</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Negative Revenue Trend: Examining Belden's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -16.53% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 6.97%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.21%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Belden's ROA excels beyond industry benchmarks, reaching 1.17%. This signifies efficient management of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 1.11, Belden faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Belden Stands With Analysts

During the last three months, 4 analysts shared their evaluations of Moody's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>), revealing diverse outlooks from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $408.5, along with a high estimate of $454.00 and a low estimate of $374.00. Observing a 5.22% increase, the current average has risen from the previous average price target of $388.25. 
<img src="https://www.benzinga.com/files/images/story/2024/1720184430_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of Moody's by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$392.00</td>
<td>$374.00</td>
</tr>
<tr>
<td>Owen Lau</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$454.00</td>
<td>$424.00</td>
</tr>
<tr>
<td>Shlomo Rosenbaum</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$374.00</td>
<td>$350.00</td>
</tr>
<tr>
<td>Jeffrey Meuler</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$414.00</td>
<td>$405.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Moody's. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Moody's compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Moody's's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Moody's's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MCO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Moody's analyst ratings.</a>
<h2>Unveiling the Story Behind Moody's</h2>
Moody's, along with S&amp;P Ratings, is a leading provider of credit ratings on fixed-income securities. The ratings segment, Moody's Investors Service, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's profit and about half the firm's revenue. The other segment, Moody's Analytics, consists of decision solutions, research and insights, and data and information.
<h3>Financial Insights: Moody's</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Over the 3 months period, Moody's showcased positive performance, achieving a revenue growth rate of 21.5% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Moody's's net margin excels beyond industry benchmarks, reaching 32.31%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Moody's's ROE excels beyond industry benchmarks, reaching 16.74%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Moody's's ROA stands out, surpassing industry averages. With an impressive ROA of 3.89%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Moody's's debt-to-equity ratio stands notably higher than the industry average, reaching 2.05. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.